Neurokinin 3 receptors in the gut: a new target for the treatment of visceral pain?
Mayer
E A
EA
Carlos Marvizon
J
J
D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D007211:Indoles / Q000627:therapeutic use; D054833:Isoindoles; D051379:Mice; D018345:Mice, Knockout; D064729:Neurokinin-1 Receptor Antagonists; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D051381:Rats; D018042:Receptors, Neurokinin-3 / Q000037:antagonists & inhibitors* / Q000502:physiology; D013373:Substance P / Q000502:physiology; D017833:Visceral Afferents / Q000187:drug effects / Q000502:physiology
D000700:Analgesics; D007211:Indoles; D054833:Isoindoles; D064729:Neurokinin-1 Receptor Antagonists; D018042:Receptors, Neurokinin-3; C071693:7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one; D013373:Substance P